Announcements Trials
Browse Landscape

Phase

Phase 2 51Phase 1/2 23Phase 1 12Phase 3 4Phase 4 3Phase NA 2Phase EARLY_PHASE1 2Phase 2/3 2

Status

Completed 57Active not recruiting 37Recruiting 21Terminated 9Withdrawn 4Unknown 4Not yet recruiting 3

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Sarcoma 1CNS 1

Conditions

Squamous Non-small Cell Lung Cancer 1Sarcoma 1Radiation Pneumonitis 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Cisplatin 129Radiotherapy 94Carboplatin 82Fluorouracil 77Paclitaxel 76Cyclophosphamide 76Gemcitabine 71Capecitabine 66Docetaxel 64Doxorubicin 59Oxaliplatin 57Etoposide 57Leucovorin 48Vincristine 46Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Pemetrexed 27Neoadjuvant Therapy 26Irinotecan 25Tamoxifen 24Prednisone 23Methotrexate 21Rituximab 19Vinorelbine 18Radiotherapy, Intensity-Modulated 18Peripheral Blood Stem Cell Transplantation 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Nivolumab × Clear all
NCT06031597 2023-09-13

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Zhejiang Cancer Hospital

Phase 3 Unknown
105 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

NCT04741438 2023-08-30

RAR-Immune

Centre Leon Berard

Phase 3 Unknown
96 enrolled
Sarcoma

Sarcoma

NCT03542461 2022-10-03

EDEN

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 3 Unknown
125 enrolled
Thoracic

Squamous Non-small Cell Lung Cancer

NCT02460068 2015-06-02

NIBIT-M2

Italian Network for Tumor Biotherapy Foundation

Phase 3 Unknown
168 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡